Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients

Recruiting

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(26 sites)

Belgium

Imelda Bonheiden, Bonheiden

AZ St.Jan, Bruges

ZOL Genk, Genk

UZ Leuven, Leuven

AZ Delta, Roeselare

Czechia

FN BRNO, Brno

Masaryk Hospital Usti nad Labem -, Hradec Králové

Charles University Hospital, Prague

Germany

Asklepios Klinik Bad Oldesloe, Bad Oldesloe

Segeberger Kliniken, Bad Segeberg

University hospital Dresden, Dresden

Italy

Ospedale Papa Giovanni XXIII, Bergamo

University of Ferrara, Ferrara

University San Martino, Genova

Centro Cardiologico Monzino IRCCS, Milan

University Federico II, Naples

University Gemelli, Roma

Netherlands

Albert Schweitzer ziekenhuis, Dordrecht

Catherina ziekenhuis, Eindhoven

RadboudUMC, Nijmegen

Erasmus Medical Center, Rotterdam

Maasstadziekenhuis, Rotterdam

Haga hospital, The Hague

Serbia

Institute for CVD Dedinje, Belgrade

University clinical center of Serbia, Belgrade

Institute for CVD Vojvodine, Kamenitz